menu
techminis

A naukri.com initiative

google-web-stories
Home

>

Bio News

>

Breakthrou...
source image

Bioengineer

2w

read

12

img
dot

Image Credit: Bioengineer

Breakthrough Blood Test Delivers Rapid Diagnosis for Thousands of Rare Genetic Disorders

  • A groundbreaking proteomic test for rapid diagnosis of rare genetic disorders in infants and children has been developed by Dr. Daniella Hock and her team at the University of Melbourne.
  • This novel approach accelerates diagnosis by examining thousands of proteins in blood samples, providing insights into the underlying genetic mutations causing diseases.
  • The test covers a wide range of genetic disorders, enhancing diagnostic accuracy and enabling earlier therapeutic interventions for improved patient outcomes.
  • Incorporating trio analysis with blood samples from the patient and both parents helps differentiate affected individuals from carriers of recessive mutations, aiding in reproductive counseling.
  • The rapid and accurate molecular diagnosis offered by this test reduces the need for invasive procedures, offering patients timely access to targeted therapies and improved prognostic clarity.
  • Economically, the proteomic test is comparable in cost to existing genetic tests but reduces overall healthcare expenditure by consolidating multiple tests into a single platform.
  • The scientific community views this innovation positively, emphasizing its potential to reshape diagnostic practices and enhance patient care globally.
  • By focusing on peripheral blood mononuclear cells, the test provides critical information about functional consequences of genetic variants, aiding in understanding systemic manifestations of diseases.
  • The proteomic analysis can expedite the discovery of novel disease genes and bridge gaps in knowledge, accelerating the translation of genomic data into actionable clinical insights.
  • Overall, this pioneering proteomic test offers a cost-effective and broadly applicable solution that promises to revolutionize rare disease diagnosis, empower families, and alleviate burdens on healthcare systems.

Read Full Article

like

Like

For uninterrupted reading, download the app